Bixin protects mice against ventilation-induced lung injury in an NRF2-dependent manner

Shasha Tao, Montserrat Rojo De La Vega, Hector Quijada, Georg T. Wondrak, Ting Wang, Joe G.N. Garcia, Donna D. Zhang

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


Mechanical ventilation (MV) is a therapeutic intervention widely used in the clinic to assist patients that have difficulty breathing due to lung edema, trauma, or general anesthesia. However, MV causes ventilator-induced lung injury (VILI), a condition characterized by increased permeability of the alveolar-capillary barrier that results in edema, hemorrhage, and neutrophil infiltration, leading to exacerbated lung inflammation and oxidative stress. This study explored the feasibility of using bixin, a canonical NRF2 inducer identified during the current study, to ameliorate lung damage in a murine VILI model. In vitro, bixin was found to activate the NRF2 signaling pathway through blockage of ubiquitylation and degradation of NRF2 in a KEAP1-C151 dependent manner; intraperitoneal (IP) injection of bixin led to pulmonary upregulation of the NRF2 response in vivo. Remarkably, IP administration of bixin restored normal lung morphology and attenuated inflammatory response and oxidative DNA damage following MV. This observed beneficial effect of bixin derived from induction of the NRF2 cytoprotective response since it was only observed in Nrf2 +/+ but not in Nrf2 mice. This is the first study providing proof-of-concept that NRF2 activators can be developed into pharmacological agents for clinical use to prevent patients from lung injury during MV treatment.

Original languageEnglish (US)
Article number18760
JournalScientific reports
StatePublished - Jan 5 2016

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Bixin protects mice against ventilation-induced lung injury in an NRF2-dependent manner'. Together they form a unique fingerprint.

Cite this